NDC 59572-515 – Abecma

Idecabtagene Vicleucel 300000000 1/1 · Suspension · Intravenous

Cellular Therapy

Product NDC59572-515

Product details

Brand name
Abecma
Generic name
Idecabtagene vicleucel
Labeler
Celgene Corporation
Dosage form
Suspension
Route
Intravenous
Marketing category
BLA · BLA125736
Marketed since
March 26, 2021
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Abecma →

Package NDC codes (3)

Package NDCDescriptionSince
59572-515-011 SUSPENSION in 1 BAG (59572-515-01)Mar 26, 2021
59572-515-021 SUSPENSION in 1 BAG (59572-515-02)Mar 26, 2021
59572-515-031 SUSPENSION in 1 BAG (59572-515-03)Mar 26, 2021